Baird Medical End Period Cash Flow Over Time
| BDMD Stock | 2.30 0.10 4.17% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Baird Medical Performance and Baird Medical Correlation. Baird |
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baird Medical. If investors know Baird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baird Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Baird Medical Investment is measured differently than its book value, which is the value of Baird that is recorded on the company's balance sheet. Investors also form their own opinion of Baird Medical's value that differs from its market value or its book value, called intrinsic value, which is Baird Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baird Medical's market value can be influenced by many factors that don't directly affect Baird Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baird Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baird Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities End Period Cash Flow Analysis
Compare Baird Medical Investment and related stocks such as FactSet Research Systems, Coupang LLC, and Data3 Limited End Period Cash Flow Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDS | 15.7 M | 189 M | 196.6 M | 116.4 M | 158.9 M | 228.4 M | 194.7 M | 208.6 M | 359.8 M | 585.6 M | 681.9 M | 503.3 M | 425.4 M | 423 M | 215.9 M |
| CPNG | 739.9 M | 739.9 M | 739.9 M | 739.9 M | 739.9 M | 739.9 M | 739.9 M | 739.9 M | 739.9 M | 1.4 B | 1.4 B | 3.8 B | 3.7 B | 5.6 B | 3 B |
| PINS | 84 M | 84 M | 84 M | 84 M | 84 M | 84 M | 84 M | 84 M | 135.3 M | 677.7 M | 678.9 M | 1.4 B | 1.6 B | 1.4 B | 941.2 M |
| EYE | 32.3 M | 32.3 M | 32.3 M | 32.3 M | 32.3 M | 5.6 M | 4.9 M | 4.2 M | 18 M | 40.3 M | 375.2 M | 306.9 M | 230.6 M | 151 M | 128.6 M |
| GAP | 38.9 M | 1.9 B | 1.5 B | 1.5 B | 1.5 B | 1.4 B | 1.8 B | 1.8 B | 1.4 B | 1.4 B | 2 B | 902 M | 1.3 B | 1.9 B | 1.4 B |
| SSY | 3.5 M | 2.1 M | 2.5 M | 3.6 M | 6 M | 3.3 M | 10.5 M | 3.5 M | 7.7 M | 11.2 M | 10 M | 6.8 M | 4.5 M | 7.2 M | 4.7 M |
Baird Medical Investment and related stocks such as FactSet Research Systems, Coupang LLC, and Data3 Limited End Period Cash Flow description
My Equities
My Current Equities and Potential Positions
| Baird Medical Investment | BDMD |
Specialization | Healthcare, Medical Devices |
| Location | Hong Kong |
| Exchange | NASDAQ Exchange |
null 2.3
Check out Baird Medical Performance and Baird Medical Correlation. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Baird Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.